09/03/2026
Women's Health | Uterine Fibroids 👩⚕️
Within the broader women's health landscape, uterine fibroids (UF) remain one of the most prevalent benign gynecological conditions worldwide.
Although many cases remain asymptomatic, symptomatic UF can manifest with heavy menstrual bleeding, pelvic pain, bulk-related symptoms, anemia, and reproductive complications, all of which may significantly impair quality of life.
Importantly, the burden of disease extends beyond physical symptoms. The chronic nature of UF-related symptoms can substantially affect patients’ daily functioning and psychological well-being. Many women report fatigue, reduced work productivity, and work absenteeism.
From a therapeutic perspective, the management of uterine fibroids has evolved considerably in recent years. Alongside surgical options such as myomectomy and hysterectomy, uterine artery embolization ( ) has emerged as an effective minimally invasive treatment.
UAE involves the targeted occlusion of uterine arteries supplying the fibroids, leading to ischemia and subsequent fibroid shrinkage. This approach has been shown to significantly reduce symptoms and improve quality of life while avoiding major surgery in selected patients.
The availability of minimally invasive options such as embolization highlights the importance of amultidisciplinary approachinvolving gynecologists, interventional radiologists, and other specialists to optimize individualized treatment pathways.
Figures 1,2,3,4 represent a case of UAE.
Case courtesy: Dr. Carolina Lanza, Fondazione Ca' Granda Ospedale Policlinico di Milano